Showing 1-10 of about 94 articles.
ACETO Corporation
ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y., May 9, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.055 per common share. This quarterly cash dividend will be distributed on June 25, 2013 to shareholders of record as of June 14, 2013.
ACETO Corporation
ACETO Corporation Schedules Fiscal 2013 Third Quarter Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y., April 26, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that it will issue its financial results of operations for its fiscal 2013 third quarter ended March 31, 2013 after the stock market closes on Thursday, May 9, 2013. On Friday, May 10, 2013 at 9:00 a.m. ET, the Company will conduct a conference call to discuss the results.
ACETO Corporation
ACETO Announces Management Transition at Its Rising Pharmaceuticals Subsidiary
PORT WASHINGTON, N.Y., April 24, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today that Ronald Gold and David Rosen, former owners of the Rising Pharmaceuticals business acquired by ACETO in December 2010, informed the Company that they intend to pursue other opportunities apart from ACETO upon the expiration of their three-year employment agreements on December 31, 2013.
ACETO Corporation
ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y., Feb. 7, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.055 per common share. This quarterly cash dividend will be distributed on March 26, 2013 to shareholders of record as of March 15, 2013.
ACETO Corporation
ACETO Corporation Schedules Fiscal 2013 Second Quarter Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y., Jan. 24, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that it will issue its financial results of operations for its 2013 fiscal second quarter ended December 31, 2012 after the stock market closes on Thursday, February 7, 2013. On Friday, February 8, 2013, at 9:00 a.m. ET, Salvatore Guccione, Ronald Gold and Douglas Roth will conduct a conference call.
ACETO Corporation
ACETO Subsidiary, Rising Pharmaceuticals, Launches First Generic Version of Grifulvin V(R)
PORT WASHINGTON, N.Y., Dec. 11, 2012 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals Inc., its finished dosage form generics subsidiary, launched the first generic version of the 500 mg strength (microsize) of Griseofulvin Tablets USP, an FDA approved generic version of Valeant Pharmaceutical's Grifulvin V®. According to IMS Health data, U.S. market sales for Griseofulvin tablets, an antifungal antibiotic that fights infections caused by fungus, were approximately $13 million for the twelve months ended June 30, 2012. The launch of the 500 mg strength of Griseofulvin tablets USP follows the previously announced launch of the first generic version of the 125mg and 250mg strengths of Ultramicrosize Griseofulvin tablets USP by Rising Pharmaceuticals in November 2012.
ACETO Corporation
ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y., Dec. 6, 2012 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.055 per common share. This quarterly cash dividend will be distributed on December 28, 2012 to shareholders of record as of December 17, 2012.
ACETO Corporation
ACETO to Present at the Oppenheimer 23rd Annual Healthcare Conference
PORT WASHINGTON, N.Y., Nov. 28, 2012 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that Salvatore Guccione, President and COO, and Doug Roth, Chief Financial Officer, are scheduled to present at the Oppenheimer 23
Showing 1-10 of about 94 articles.